Patent · US Active

Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins

US10662193B2 · kind B2 · utility

1Cited by

0References

14Claims

0Family size

Assignees

AC Immune SA · CH
LIFE MOLECULAR IMAGING SA · CH

Inventors

Heiko Kroth · Ecublens, CH
Sreenivasachary Nampally · Ecublens, CH
Jér{hacek over (o)}me Molette · Ferney-Voltaire, FR
Emanuele Gabellieri · Lausanne, CH
Pascal Benderitter · Orbe, CH
Wolfgang Froestl · Ecublens, CH
Hanno Schieferstein · Berlin, DE
Andre Mueller · Berlin, DE
Heribert Schmitt-Willich · Berlin, DE
Mathias Berndt · Berlin, DE

Key dates

Filing date	Jan 21, 2015
Grant date	May 26, 2020
Priority date	—
Expiry date	Jan 21, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.